Muramyl dipeptide (MDP) is a synthetic immunoadjuvant peptide that promotes bone formation. It directly enhances osteoblast differentiation via Runx2 upregulation through MAPK signaling, while indirectly suppressing osteoclastogenesis by modulating the RANKL/OPG ratio. This makes it a valuable tool for studying bone metabolism and immunology in both cellular and animal models.
